Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Nov 11, 2025

Fortis Healthcare Q2 Results: Net Profit Surges 82.4%, Beats Estimates

The firm's earnings before interest, taxes, depreciation and amortisation also spiked 27.8% to Rs 556 crore from the previous fiscal's Rs 435 crore.

Fortis Healthcare Q2 Results: Net Profit Surges 82.4%, Beats Estimates
The revenue saw sharp 17.3% increase to Rs 2,331 crore from the previous year's Rs 1,988 crore. (Image source: Fortis Healthcare website).
  • Fortis Healthcare's Q2 net profit rose 82.4% to Rs 322 crore year-on-year
  • Revenue increased 17.3% to Rs 2,331 crore, beating Bloomberg estimates
  • EBITDA grew 27.8% to Rs 556 crore with margin expanding to 23.9%

Fortis Healthcare Ltd. reported a net profit of 82.4% for its consolidated second quarter earnings taken on a year-on-year ear basis.

The company on Tuesday reported a net profit of Rs 322 crore compared to the year ago period's Rs 176 crore. The profit exceeded the Bloomberg estimate of Rs 274 crore.

The revenue saw sharp 17.3% increase to Rs 2,331 crore from the previous year's Rs 1,988 crore. The revenue surpassed the Bloomberg estimate of Rs 2,297 crore.

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

The firm's earnings before interest, taxes, depreciation and amortisation also spiked 27.8% to Rs 556 crore from the previous fiscal's Rs 435 crore. The amount beat the Bloomberg estimate of Rs 528 crore.

Ebitda margin expanded notable by 23.9% from 21.9%, in line with the Bloomberg estimate of 23%.

Fortis Healthcare Q2 Highlights (Consolidated, Year-over-Year)

  • Revenue strongly up 17.3% to Rs 2,331 crore versus Rs 1,988 crore.

  • Ebitda up 27.9% to Rs 556 crore versus Rs 435 crore.

  • Margin significantly expanded to 23.9% versus 21.9%.

  • Net Profit surged by an outstanding 82.4% to Rs 322 crore versus Rs 176 crore.

Shares of Fortis Healthcare closed 0.89 % lower at Rs 986.90 apiece on the NSE, compared to a 0.47% rise in the benchmark Nifty. The stock had risen 58.17% in the last 12 months and 37.1% on a year-to-date basis.

Out of 16 analysts tracking the company, 15 have a 'buy' rating on the stock, and one suggests 'sell', according to Bloomberg data. The average of 12-month analysts' price target implies a potential upside of 2.7%.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices, Watch Business News Live and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Listen to the latest songs, only on JioSaavn.com